Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousLiver TransplantationTransplantation ConditioningBone Marrow TransplantationPeripheral Blood Stem Cell TransplantationKidney TransplantationGraft vs Host DiseaseCell TransplantationATP Binding Cassette Transporter 1Apolipoprotein A-ICholesterolCells, CulturedLipoproteins, HDLGraft SurvivalHematologic NeoplasmsHeart TransplantationTissue DonorsTransplantation ChimeraLung TransplantationTreatment OutcomeCord Blood Stem Cell TransplantationATP-Binding Cassette TransportersBiological TransportCell DifferentiationOrgan TransplantationGraft RejectionImmunosuppressive AgentsTransplantation ImmunologyMyeloablative AgonistsIslets of Langerhans TransplantationHistocompatibility TestingRetrospective StudiesWhole-Body IrradiationTransplantationGene Expression RegulationRecurrenceFibroblastsMesenchymal Stem Cell TransplantationPancreas TransplantationBusulfanHistocompatibilityTime FactorsTransplantation, IsogeneicCell LineCombined Modality TherapyRemission InductionMultiple MyelomaMelphalanSurvival AnalysisLiving DonorsSurvival RateLeukemiaImmunosuppressionPeripheral NervesGraft vs Leukemia EffectFollow-Up StudiesVidarabineDisease-Free SurvivalHLA AntigensTransplantation ToleranceCyclophosphamideHematopoietic Stem Cell MobilizationTransplantation, HeterotopicGraft vs Tumor EffectLeukemia, Myeloid, AcuteChimerismAntineoplastic Combined Chemotherapy ProtocolsUnrelated DonorsT-LymphocytesHeart-Lung TransplantationHepatic Veno-Occlusive DiseaseCyclosporineAntigens, CD34Tissue and Organ ProcurementSiblingsAntilymphocyte SerumSalvage TherapyFetal Tissue TransplantationLymphocyte TransfusionLymphoma, Non-HodgkinHematologic DiseasesMyelodysplastic SyndromesDonor SelectionCytomegalovirus InfectionsTransplantation, HeterologousAcute DiseaseHematopoietic Stem CellsLiver FailurePostoperative ComplicationsPrognosisLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaAnemia, AplasticGranulocyte Colony-Stimulating FactorTacrolimusRisk FactorsLeukemia, Myelogenous, Chronic, BCR-ABL Positive